Cogent Biosciences News

Cogent Biosciences | 8-K: Current report

Sep 3 20:21

Cogent Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 7 04:59

Cogent Biosciences | 8-K: Current report

Jun 27 20:07

Cogent Biosciences | 8-K: Current report

Jun 6 04:10

Cogent Biosciences | DEFA14A: Others

Apr 24 04:38

Cogent Biosciences | DEF 14A: Definitive information statements

Apr 24 04:38

Cogent Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 13 04:36

Cogent Biosciences | S-3: Registration statement for specified transactions by certain issuers

Mar 30 04:14

Cogent Biosciences | 8-K: Current report

Mar 22 20:36

Cogent Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 05:37

Cogent Biosciences | 8-K: Current report

Feb 14 21:37

Cogent Biosciences | 8-K: Current report

Dec 11, 2023 21:04

Cogent Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 9, 2023 04:31

Cogent Biosciences | 8-K: Current report

Jun 9, 2023 04:31

Cogent Biosciences | 8-K: Current report

Jun 8, 2023 04:24

Cogent Biosciences | 8-K: Current report

Jun 7, 2023 04:03

Cogent Biosciences | DEFA14A: Others

Apr 26, 2023 04:06

Cogent Biosciences | DEF 14A: Definitive proxy statements

Apr 26, 2023 04:02

Cogent Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 15, 2023 04:02

Cogent Biosciences | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 11, 2023 05:57